Valeo Pharma Inc (TSE:VPH) has released an update.
Valeo Pharma Inc., a Canadian pharmaceutical firm, has enhanced its Board of Directors with the addition of Mr. Al Moghaddam, a seasoned executive recognized for his value creation and growth delivery in the pharmaceutical industry. With over 25 years of global experience across various sectors including pharma and med-tech, Mr. Moghaddam is expected to bring valuable insight and leadership to the company. Valeo specializes in commercializing innovative prescription products in Canada, focusing on Respiratory/Allergy, Ophthalmology, and Hospital Specialty Products.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.
